SCN2B

SCN2B encodes the voltage-gated sodium channel β2 subunit, an immunoglobulin-superfamily transmembrane glycoprotein that covalently associates with pore-forming α subunits via an extracellular disulfide bond at Cys-26 and functions as a chaperone, gating modulator, and cell adhesion molecule. β2 promotes surface delivery of Nav1.5 and neuronal Nav α subunits through a trafficking mechanism that requires N-glycosylation for ER export, involves homodimerization and integrity of all three protein domains, and is disrupted by arrhythmia-associated mutations such as D211G (PMID:31511323, PMID:39343005, PMID:28597987). β2 opposes β1-mediated inactivation by increasing persistent sodium current, and co-expression of β1 and β2 produces hybrid gating distinct from either subunit alone, while also modifying pharmacological sensitivity of the channel complex (PMID:19228957, PMID:37544648, PMID:20573896). Loss of β2 in vivo reduces neuronal and cardiac sodium channel surface expression, causing ventricular arrhythmias, atrial fibrillation susceptibility, altered pain sensitivity, and neuroprotection in demyelinating disease (PMID:27932425, PMID:19013247, PMID:21555511).

1. 2008 High

   The in vivo requirement for β2 was established: Scn2b-null mice showed reduced neuronal Na+ channel surface expression, impaired conduction, and unexpected neuroprotection in EAE, demonstrating that β2 functions as an essential chaperone for α subunit plasma membrane delivery in the nervous system.

   Evidence Scn2b knockout mouse with EAE induction, axonal degeneration assessment, and electrophysiology

   PMID:19013247

   Open questions at the time

   • Mechanism by which reduced surface Na+ channels confer neuroprotection was not resolved
   • Cardiac phenotype of the knockout was not yet examined
2. 2009 High

   Two complementary studies defined β2's biophysical role and disease relevance: β2 increases persistent Na+ current (INaP) in opposition to β1-mediated inactivation, and SCN2B mutations (R28Q, R28W) that reduce sodium current density were linked to atrial fibrillation susceptibility.

   Evidence Patch-clamp in HEK cells and hippocampal neurons from Scn1b/Scn2b null mice; heterologous expression of mutant β2 with Nav1.5 in CHO cells

   PMID:19228957 PMID:19808477

   Open questions at the time

   • Whether AF-linked mutations disrupt trafficking versus gating was unresolved
   • Antagonistic β1/β2 interplay was not yet tested in cardiac cells
3. 2010 High

   β2 was shown to modulate not only biophysical but also pharmacological properties of Na+ channels, as carbamazepine effects on INaP were altered in Scn2b-null hippocampal neurons, expanding the functional scope of β2 beyond gating.

   Evidence Whole-cell patch-clamp on CA1 neurons from Scn2b-null mice with computational modeling

   PMID:20573896

   Open questions at the time

   • Whether β2 alters drug binding directly or indirectly through channel conformation was not distinguished
4. 2011 High

   β2's opposing role to β1 was confirmed in cardiac myocytes, and its regulation of neuronal α subunit expression in nociceptors was identified: SCN2B knockdown in ventricular cardiomyocytes increased late Na+ current, while Scn2b-null DRG neurons showed selective changes in TTX-sensitive α subunit expression affecting pain sensitivity.

   Evidence siRNA knockdown in canine cardiomyocytes with patch-clamp; Scn2b-null mouse DRG neuron electrophysiology and behavioral assays

   PMID:21555511 PMID:21705762

   Open questions at the time

   • Mechanism by which β2 regulates α subunit mRNA levels in DRG was not identified
   • Whether β1/β2 opposition in late current applies to all cardiac α subunit isoforms was untested
5. 2012 High

   The molecular basis of α–β2 covalent association was pinpointed: Cys-26 in the Ig domain forms the single disulfide bond to α subunits, and this linkage is required for β2 targeting to nodes of Ranvier, the axon initial segment, and cytoskeletal association.

   Evidence Site-directed mutagenesis of Cys-26; myelinating co-cultures; primary hippocampal neuron imaging; detergent extraction

   PMID:22992729

   Open questions at the time

   • Identity of the partnering cysteine on the α subunit was not mapped
   • Whether non-covalent β2–α interactions persist in Cys-26 mutants was not fully resolved
6. 2013 High

   The Brugada syndrome-associated β2 mutation D211G was shown to reduce Nav1.5 surface expression without affecting unitary conductance, establishing that disease-linked β2 variants can specifically disrupt the trafficking function for α subunits.

   Evidence Heterologous co-expression; whole-cell and single-channel patch-clamp; surface biotinylation

   PMID:23559163

   Open questions at the time

   • Whether D211G disrupts β2 folding, dimerization, or α subunit interaction was unknown
7. 2016 High

   The cardiac phenotype of Scn2b loss was comprehensively characterized: null mice exhibited reduced Na+ and K+ current densities, right ventricular conduction slowing, spontaneous polymorphic VT, and atrial fibrillation with fibrosis, with unchanged total Nav1.5 protein—confirming β2's cardiac trafficking role in vivo.

   Evidence Scn2b knockout mouse; patch-clamp; in vivo cardiac electrophysiology; western blot; histology

   PMID:27932425

   Open questions at the time

   • Mechanism of K+ current reduction in β2-null cardiomyocytes was unexplained
   • Basis of atrial fibrosis was not resolved
8. 2017 High

   Two studies expanded β2 biology: β2 D211G was shown to reach the plasma membrane itself but fail to promote Nav1.5 surface delivery, dissociating β2 self-trafficking from its α-chaperoning function; separately, β2 was identified as a BACE1 substrate whose cleavage in AD models alters APP processing and cognition.

   Evidence Polarized MDCK/HL-1 cells with confocal imaging and surface biotinylation; Nav β2 knockdown in APP/PS1 mice with electrophysiology, EEG, and behavioral testing

   PMID:28597987 PMID:29245901

   Open questions at the time

   • D211G structural defect was not identified at atomic resolution
   • BACE1 cleavage site on β2 was not mapped
   • AD-related findings from a single lab
9. 2019 High

   N-glycosylation at Asn-42, Asn-66, and Asn-74 was mapped, with sialylation restricted to Asn-42; complete loss of glycosylation caused ER retention of β2 and failure to promote Nav1.5 surface delivery, establishing glycosylation as a prerequisite for β2 trafficking competence.

   Evidence N-glycosylation site mutagenesis; biochemical glycosylation assays; FRAP; surface biotinylation in polarized MDCK cells

   PMID:31511323

   Open questions at the time

   • Contribution of individual glycosylation sites to trafficking efficiency was not fully resolved
   • Whether glycosylation affects β2 interaction with specific α subunits was untested
10. 2020 Medium

    A crystal structure of β2 (R137H variant) was obtained, revealing local structural changes at the mutation site without global destabilization; R137H had no effect on Nav1.5, suggesting it may act through other α subunit subtypes.

    Evidence X-ray crystallography; patch-clamp electrophysiology on Nav1.5

    PMID:34476357

    Open questions at the time

    • Wild-type β2 structure was not determined for comparison
    • Effect of R137H on non-Nav1.5 α subunits was not tested
    • Structure was of a disease variant, not wild-type
11. 2021 High

    S-palmitoylation at Cys-182 was identified as a post-translational modification that directs β2 to lipid rafts and controls its polarized localization, independent of its α-chaperoning function.

    Evidence Acyl-biotin exchange; cholesterol depletion; lipid raft fractionation; FRAP; confocal imaging in polarized MDCK cells

    PMID:33602743

    Open questions at the time

    • Palmitoylating enzyme(s) for β2 were not identified
    • Whether palmitoylation affects β2 function in cardiomyocytes or neurons was not tested in vivo
12. 2023 High

    Using a CRISPR-engineered β-subunit-null human cell line, each β subunit was shown to confer unique gating properties to Nav1.5, and co-expression of β1+β2 produced hybrid gating distinct from either alone—providing a clean demonstration of combinatorial β subunit regulation.

    Evidence β-subunit-null haploid human cells (BeHAPe); heterologous expression; whole-cell patch-clamp

    PMID:37544648

    Open questions at the time

    • Whether hybrid gating occurs in native cardiomyocytes was not verified
    • Stoichiometry of β1/β2 in the native complex was not determined
13. 2024 High

    β2 was shown to form homodimers, and systematic domain deletion revealed that the cytoplasmic tail, extracellular Ig loop, and transmembrane domain are each required for proper folding and ER export, while Nav1.5 does not influence β2 trafficking—establishing that β2 traffics autonomously.

    Evidence Domain deletion mutagenesis; co-immunoprecipitation; glycosylation assays; confocal imaging in MDCK cells

    PMID:39343005

    Open questions at the time

    • Homodimer interface residues were not mapped at atomic resolution
    • Functional significance of homodimerization for α subunit chaperoning was not determined

• Key unresolved questions include: the structural basis of β2-mediated α subunit trafficking (no co-structure with an α subunit exists), the identity of palmitoylating enzymes, the physiological significance of β2 homodimerization, the mechanism by which β2 loss leads to cardiac fibrosis, and whether BACE1 cleavage of β2 is pathophysiologically relevant in human Alzheimer's disease.
• No α–β2 co-crystal or cryo-EM structure
• Palmitoyl acyltransferase identity unknown
• In vivo significance of β2 homodimerization untested
• BACE1–β2 axis in human AD not validated